CMA slaps Advanz with £100 million in fines for over pricing of thyroid drug
The Competition and Markets Authority (CMA) has imposed more than £100 million in fines on Advanz for inflating the price of thyroid tablets.
The pharma...
Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy
Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc